Skip to main content

Table 2 Baseline characteristics of subjects regarding different combinations of glucose tolerance statuses and general obesity among women

From: The impact of obesity on different glucose tolerance status with incident cardiovascular disease and mortality events over 15 years of follow-up: a pooled cohort analysis

Variables

NGT

Pre-diabetes

Type 2 diabetes

Non-obese (n = 4960)

Obese (n = 1722)

Non-obese (n = 1379)

Obese (n = 950)

Non-obese (n = 384)

Obese (n = 532)

Age (years)

48.7(7.5)

48.5(7.3)

51.9(5.5)

51.3(5.9)

52.9(5.8)

52.3(5.3)

SBP (mmHg)

112.3(16.1)

120.1(17.4)

119.3(18.7)

124.9(17.7)

125.4(20.6)

130.4(20.2)

DBP (mmHg)

71.0(10.0)

76.8(10.1)

73.3(10.3)

77.4(10.1)

74.8(10.2)

77.7(11.0)

BMI (kg/m2)

24.9(2.9)

33.8(3.6)

25.6(2.8)

35.1(4.6)

26.5(2.5)

35.6(4.7)

WC (cm)

86.4(9.4)

105.6(11.2)

89.7(9.4)

110.5(12.3)

93.7(8.3)

113.8(12.3)

Non-HDL-C (mg/dl)

144.0(120.1–172.0)

156.0(183.0–132.0)

159.0(133.0–189.2)

165.1(136.7–193.0)

168.0(139.0–201.0)

171.0(142.0–205.0)

FPG (mg/dl)

89.6(85.0–94.0)

90.7(86.0–95.0)

105.0(102.0–109.0)

107.0(103.0–112.7)

157.0(130.0–218.0)

165.0(134.0–241.5)

Education, years

  < 6

343(6.9)

287(16.7)

75(5.4)

131(13.8)

76(19.8)

102(19.2)

 6–12

1231(24.8)

586(34.0)

270(19.6)

292(30.7)

97(25.3)

161(30.3)

  ≥ 12

3386(68.3)

849(49.3)

1034(75.0)

527(55.5)

211(54.9)

269(50.5)

Current smoker(yes)

1021(20.6)

225(13.1)

352(25.5)

142(14.9)

76(19.8)

98(18.4)

Hypertension (yes)

940(19.0)

549(31.9)

489(35.5)

480(50.5)

191(49.7)

332(62.4)

FH-CVD (yes)

746(15.0)

255(14.8)

170(12.3)

1234(12.9)

68(17.7)

93(17.5)

Prevalent CVD (yes)

65(1.3)

36(2.1)

40(2.9)

40(4.2)

21(5.5)

43(8.1)

  1. Continuous variables are shown as mean (standard deviation; SD) for normal distribution and median (interquartile range: IQR) for skewed variables (e.g. FPG, non-HDL-C), and categorical variables are presented as number (%)
  2. ARIC Atherosclerosis Risk in Communities, MESA Multi-Ethnic Study of Atherosclerosis, TLGS Tehran Lipid and Glucose Study, FPG fasting plasma glucose, SBP systolic blood pressure, DBP diastolic blood pressure, BMI body mass index, WC waist circumference, FPG fasting plasma glucose, non-HDL-C non-high-density lipoprotein cholesterol, FHCVD family history cardiovascular disease, CVD cardiovascular disease, NGT normal glucose tolerance. General obesity (BMI ≥ 30 kg/m2)
  3. Normoglycemia: FPG < 100 mg/dl & no medication; pre-diabetes: FPG 100–126 mg/dl and no medication; type 2 diabetes; FPG ≥ 126 mg/dl or using medication